ADMA Biologics to Present at Upcoming Investor Conferences

NEXT STORY
Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5
PREV STORY
Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Safety Needles Markets; World Forecast to 2026 Featuring B. Braun, BD, Cardinal Health, J&J, Nipro, Novo Nordisk, and More

author_avatar
NASDAQ Market News

Ultimovacs ASCO Phase I data shows 60% ORR in advanced melanoma with UV1/pembrolizumab, supporting broad Phase II combination program

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals to Participate in Upcoming January Conferences

author_avatar
NASDAQ Market News